Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Trastuzumab × Clear all

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Urologic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT01953926 2024-03-12

SUMMIT

Phase 2 Terminated

582 enrolled 27 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT03845270 2023-12-19

R2D2

Phase 2 Completed

46 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04591431 2023-10-03

ROME

Phase 2 Unknown

400 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT00016367 2018-10-26

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

22 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003881 2013-06-21

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Phase 2 Completed

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00758134 2013-05-29

Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients

Phase 2 Terminated

9 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00004883 2013-01-16

Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2

Phase 2 Completed

84 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

SUMMIT

R2D2

ROME

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients

Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2